Two cases report combined breast reconstruction and risk-reducing surgeries in HBOC patients, suggesting improved outcomes.
Breast cancer is the most common malignancy among women, with a lifetime risk of more than 10%. Hereditary breast and ovarian cancer syndrome (HBOC) is an autosomal dominant disorder characterized by pathogenic variants in the BRCA1/2 genes. HBOC dramatically increases the risk of breast and ovarian cancers. After the inclusion of BRCA testing and risk-reducing surgeries (mastectomy with reconstruction and salpingo-oophorectomy) in health insurance coverage in April 2020, it is expected that more patients will be diagnosed with HBOC and require treatment. Given the prophylactic nature of these procedures, there is a high demand for breast reconstruction, making the role of plastic surgeons crucial. Given patients with HBOC frequently require multiple operations, a multidisciplinary approach involving combined surgical procedures can significantly reduce the number of interventions, offering substantial physical and psychological benefits. Here, we present our experience with a combined procedure performed with the gynecology department, comparing it with traditional surgical approaches and addressing the challenges encountered.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: